Clinical Trials Browser

Phase 1/2 × chiauranib × Gastrointestinal × Clear all

NCT03245190 2021-06-18

Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular